Clinical study of rezvilutamide inhibiting the flare effect of GnRH agonists in the treatment of newly diagnosed metastatic prostate cancer.

被引:0
|
作者
Wang, Shaogang
Wang, Zhihua
Hu, Zhiquan
Yang, Chunguang
机构
[1] Huazhong Univ Sci & Technol, Wuhan, Peoples R China
[2] Huazhong Univ, Tongji Hosp, Tongji Med Coll, Urol Dept, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Urol, Wuhan, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
关键词
3282-3221-3717; 261-566-9690; 3282-3221-2748-2527; 613-225-2575-2447; 283-2494-5577-5578; 261-436; 613-135-4642-282-153; 6; 5; 4; 2; 1917; 138; 73; 238; 3; 1; 38092-25779;
D O I
10.1200/JCO.2024.42.4_suppl.TPS233
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:TPS233 / TPS233
页数:1
相关论文
共 50 条
  • [1] Differential treatment response of prostate and metastatic lesions in patients with newly diagnosed metastatic prostate cancer.
    Esen, Baris
    Seymen, Hulya
    Falay, Okan
    Tarim, Kayhan
    Kilic, Mert
    Bavbek, Sevil
    Kordan, Yakup
    Tilki, Derya
    Esen, Tarik
    Demirkol, Mehmet Onur
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] DIFFERENTIAL TREATMENT RESPONSE OF PROSTATE AND METASTATIC LESIONS IN PATIENTS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER
    Esen, Baris
    Seymen, Hulya
    Falay, Okan
    Tarim, Kayhan
    Kilic, Mert
    Bavbek, Sevil
    Kordan, Yakup
    Tilki, Derya
    Esen, Tarik
    Demirkol, Mehmet Onur
    JOURNAL OF UROLOGY, 2023, 209 : E490 - E490
  • [3] The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
    Lumen, Nicolaas
    De Bleser, Elise
    Buelens, Sarah
    Verla, Wesley
    Poelaert, Filip
    Claeys, Wietse
    Fonteyne, Valerie
    Verbeke, Sofie
    Villeirs, Geert
    De Man, Kathia
    Rottey, Sylvie
    Van Praet, Charles
    Decaestecker, Karel
    Ost, Piet
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 29 : 68 - 76
  • [4] Re: The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
    Trelles, Carlos R.
    Martinez-Pineiro, Luis
    EUROPEAN UROLOGY, 2021, 80 (06) : 764 - 765
  • [5] Clinical and biochemical factors in newly diagnosed metastatic prostate cancer: Impact on prognostication on outcomes
    Tay, Melissa
    Chiong, Edmund
    Rahman, Lata
    Liang, Shen
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 63 - 64
  • [6] GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system
    Dondi, D
    Festuccia, C
    Piccolella, M
    Bologna, M
    Motta, M
    ONCOLOGY REPORTS, 2006, 15 (02) : 393 - 400
  • [7] The effect of dual eligibility on the quality of active surveillance in patients with newly diagnosed prostate cancer.
    Faraj, Kassem S.
    Dunn, Rodney
    Hollenbeck, Brent K.
    Shahinian, Vahakn B.
    Herrel, Lindsey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 266 - 266
  • [8] The changing landscape of systemic therapy in the treatment of newly-diagnosed metastatic prostate cancer
    Lumen, N.
    Lambert, E.
    Fonteyne, V
    De Maeseneer, D.
    Van Praet, C.
    EUROPEAN UROLOGY, 2022, 81 : S774 - S775
  • [9] Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registry
    Benjamin, David J.
    Shrestha, Anshu
    Fellman, Dimitra
    Cress, Rosemary D.
    Lythgoe, Mark P.
    Kalebasty, Arash Rezazadeh
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 27 (4) : 680 - 685
  • [10] Radionuclide bone scan in patients with newly diagnosed prostate cancer.: Clinical aspects and cost analysis
    Klatte, T.
    Klatte, D.
    Boehm, M.
    Allhoff, E. P.
    UROLOGE, 2006, 45 (10): : 1293 - +